Pancreatic Cancer Research

ResearcherChina Academy of Chinese Medical SciencesNo recent work listed

Peitong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5608-7964; OpenAlex author ID A5016668940. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper

Papers 4

  1. Pancreatic cancer progression and mortality predicted by depression and anxiety: a systematic review and meta-analysis protocol. Co-author DOI 10.3389/fpsyt.2023.1266502↗
  2. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics. Last author DOI 10.1155/2022/4651432↗
  3. Efficacy and safety of traditional Chinese medicine for the treatment of pancreatic cancer: An overview of systematic reviews and meta-analyses. Co-author DOI 10.3389/fphar.2022.896017↗
  4. Different Survival Benefits of Chinese Medicine for Pancreatic Cancer: How to Choose? Last author DOI 10.1007/s11655-017-2971-1↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Wang · 3 shared papers, 2022–2023 · strength 0.64
  2. Ruoqi Zhang · 2 shared papers, 2022–2023 · strength 0.44
  3. Rui Miao · 1 shared paper, 2023 · strength 0.24
  4. Jie He · 1 shared paper, 2022 · strength 0.20
  5. Meng Li · 1 shared paper, 2018 · strength 0.09
  6. Xing Zhang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.